172 related articles for article (PubMed ID: 37375593)
1. Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model.
Gammoh O; Ibrahim A; Qnais E; Alqudah A; Altaber S; Aljabali AAA; Tambuwala MM
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375593
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the potential of vitamins C and D as adjuvants in depression treatment with escitalopram in an LPS animal model.
Gammoh O; Akasheh RT; Qnais E; Al-Taber S; Athamneh RY; Hafiz AA; Alqudah A; Aljabali AAA; Tambuwala MM
Inflammopharmacology; 2024 Apr; 32(2):1147-1157. PubMed ID: 38180676
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Roles of Vitamins C and D and Etifoxine in Combination with Citalopram in Depression/Anxiety Model: A Focus on ICAM-1, SIRT1 and Nitric Oxide.
Gammoh O; Ibrahim A; Yehya A; Alqudah A; Qnais E; Altaber S; Alrob OA; Aljabali AAA; Tambuwala MM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396638
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression.
Malki K; Lourdusamy A; Binder E; Payá-Cano J; Sluyter F; Craig I; Keers R; McGuffin P; Uher R; Schalkwyk LC
Pharmacogenet Genomics; 2012 Nov; 22(11):765-76. PubMed ID: 23026812
[TBL] [Abstract][Full Text] [Related]
6. Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress.
Shahzad N; Ahmad J; Khan W; Al-Ghamdi SS; Ain MR; Ibrahim IA; Akhtar M; Khanam R
Pharmacol Biochem Behav; 2014 Feb; 117():79-84. PubMed ID: 24361783
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
Kaminska K; Rogoz Z
J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.
Furuse K; Ukai W; Hashimoto E; Hashiguchi H; Kigawa Y; Ishii T; Tayama M; Deriha K; Shiraishi M; Kawanishi C
J Affect Disord; 2019 Mar; 247():97-104. PubMed ID: 30658246
[TBL] [Abstract][Full Text] [Related]
9. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
10. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
[TBL] [Abstract][Full Text] [Related]
11. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
Bjørnebekk A; Mathé AA; Brené S
Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram Targets Oxidative Stress, Caspase-3, BDNF and MeCP2 in the Hippocampus and Frontal Cortex of a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress.
Dionisie V; Ciobanu AM; Toma VA; Manea MC; Baldea I; Olteanu D; Sevastre-Berghian A; Clichici S; Manea M; Riga S; Filip GA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299103
[TBL] [Abstract][Full Text] [Related]
13. Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.
Mokoena ML; Harvey BH; Viljoen F; Ellis SM; Brink CB
Psychopharmacology (Berl); 2015 Aug; 232(16):2921-38. PubMed ID: 25877744
[TBL] [Abstract][Full Text] [Related]
14. Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test.
Zomkowski AD; Engel D; Gabilan NH; Rodrigues AL
Eur Neuropsychopharmacol; 2010 Nov; 20(11):793-801. PubMed ID: 20810255
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the potential of Morinda officinalis oligosaccharides as an adjuvant of escitalopram in depression treatment and exploring the underlying mechanisms.
Pan SM; Yin XY; Dai DM; Zhang LW; Qi Q; Wang PJ; Hui L; Zhu ZH
J Ethnopharmacol; 2024 Jun; 328():118124. PubMed ID: 38556138
[TBL] [Abstract][Full Text] [Related]
16. Effects of escitalopram and ibuprofen on a depression-like phenotype induced by chronic stress in rats.
Seo MK; Lee JG; Park SW
Neurosci Lett; 2019 Mar; 696():168-173. PubMed ID: 30586639
[TBL] [Abstract][Full Text] [Related]
17. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat.
Sedaghat K; Yousefian Z; Vafaei AA; Rashidy-Pour A; Parsaei H; Khaleghian A; Choobdar S
Behav Brain Res; 2019 Jan; 356():156-169. PubMed ID: 30144460
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K
Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554
[TBL] [Abstract][Full Text] [Related]
19. Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety.
Kouba BR; Camargo A; Gil-Mohapel J; Rodrigues ALS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806075
[TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action.
Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT
Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
